Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
SGLT-2 Inhibition: A Potential New Treatment for Diabetic Kidney Disease?
Robert D. Toto
Internal Medicine
Nephrology
Clinical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'SGLT-2 Inhibition: A Potential New Treatment for Diabetic Kidney Disease?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Diabetic Nephropathies
100%
Kidney Diseases
98%
empagliflozin
58%
Sodium-Glucose Transporter 2 Inhibitors
54%
Disease Progression
45%
Albuminuria
44%
Renin-Angiotensin System
39%
Glomerular Filtration Rate
35%
Sodium-Glucose Transporter 2
32%
Type 2 Diabetes Mellitus
28%
Placebos
25%
Clinical Trials
24%
Proximal Kidney Tubule
23%
Pharmaceutical Preparations
23%
Renal Replacement Therapy
21%
Hyperglycemia
17%
Renal Insufficiency
16%
Blood Glucose
15%
Therapeutics
15%
Cardiovascular Diseases
13%
Randomized Controlled Trials
12%
Kidney
10%
Population
7%